A new Alzheimer's drug is being hailed as a "turning point" in the fight against the disease, with researchers saying it marks the beginning of a "new era where Alzheimer's could become treatable".
Alzheimer’s disease is the most common cause of dementia in the UK and affects memory, thinking and other mental abilities. It is a progressive condition which means symptoms develop gradually over time and eventually become more severe.
